药物流行病学研究中药物相互作用的评估
Evaluation of Drug-Drug Interactions in Pharmacoepidemiologic Research.
作者信息
Chen Cheng, Pham Nguyen Thanh Phuong, Hughes John E, Hennessy Sean, Leonard Charles E, Miano Todd A, Douros Antonios, Gagne Joshua J, Bykov Katsiaryna
机构信息
Division of Epidemiology II, Office of Surveillance and Epidemiology, United States Food and Drug Administration, Silver Spring, Maryland, USA.
Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
出版信息
Pharmacoepidemiol Drug Saf. 2025 Jan;34(1):e70088. doi: 10.1002/pds.70088.
Abstract
Drug-drug interactions (DDIs) represent a significant concern for clinical care and public health, but the health consequences of many DDIs remain largely underexplored. This knowledge gap underscores the critical need for pharmacoepidemiologic research to evaluate real-world health outcomes of DDIs. In this review, we summarize the definitions commonly used in pharmacoepidemiologic DDI studies, discuss common sources of bias, and illustrate through examples how these biases can be mitigated.
摘要
药物相互作用（DDIs）是临床护理和公共卫生的重大关注点，但许多药物相互作用对健康的影响在很大程度上仍未得到充分探索。这一知识空白凸显了药物流行病学研究评估药物相互作用实际健康结果的迫切需求。在本综述中，我们总结了药物流行病学药物相互作用研究中常用的定义，讨论了常见的偏倚来源，并通过实例说明如何减轻这些偏倚。
相似文献
1
Evaluation of Drug-Drug Interactions in Pharmacoepidemiologic Research.药物流行病学研究中药物相互作用的评估
Pharmacoepidemiol Drug Saf. 2025 Jan;34(1):e70088. doi: 10.1002/pds.70088.
2
Pharmacoepidemiologic Methods for Studying the Health Effects of Drug-Drug Interactions.研究药物相互作用对健康影响的药物流行病学方法。
Clin Pharmacol Ther. 2016 Jan;99(1):92-100. doi: 10.1002/cpt.277. Epub 2015 Nov 23.
3
Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis.药物-药物相互作用相关的住院/就诊情况：系统评价和荟萃分析。
Pharmacoepidemiol Drug Saf. 2014 May;23(5):489-97. doi: 10.1002/pds.3592. Epub 2014 Mar 10.
4
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies.药物流行病学的核心概念：药物流行病学研究中出现的主要偏倚。
Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):9-18. doi: 10.1002/pds.5547. Epub 2022 Oct 20.
5
Methods in pharmacoepidemiology.药物流行病学方法。
Therapie. 2019 Apr;74(2):187-197. doi: 10.1016/j.therap.2018.11.015. Epub 2019 Feb 6.
6
[Identification process of time-related bias in pharmacoepidemiologic research based on a scoping review].基于范围综述的药物流行病学研究中时间相关偏倚的识别过程
Zhonghua Liu Xing Bing Xue Za Zhi. 2024 Sep 10;45(9):1273-1282. doi: 10.3760/cma.j.cn112338-20240123-00037.
7
Pharmacoepidemiological study of drug-drug interactions in onco-hematological pediatric patients.肿瘤血液科儿科患者药物相互作用的药物流行病学研究
Int J Clin Pharm. 2014 Dec;36(6):1160-9. doi: 10.1007/s11096-014-0011-1. Epub 2014 Sep 10.
8
Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.识别导致门诊患者潜在药物相互作用的高风险药物：基于在线监测系统的处方数据库研究。
Res Social Adm Pharm. 2016 Jul-Aug;12(4):559-68. doi: 10.1016/j.sapharm.2015.09.004. Epub 2015 Sep 25.
9
Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.匈牙利门诊患者中严重药物相互作用的全国流行率：基于药房配药数据的回顾性分析。
BMC Pharmacol Toxicol. 2019 May 31;20(1):36. doi: 10.1186/s40360-019-0311-0.
10
Pharmacoepidemiologic research in Australia: challenges and opportunities for monitoring patients with rheumatic diseases.澳大利亚的药物流行病学研究：监测风湿病患者的挑战与机遇
Clin Rheumatol. 2009 Apr;28(4):371-7. doi: 10.1007/s10067-009-1102-6. Epub 2009 Feb 4.
引用本文的文献
1
Effectiveness and safety of concomitant use of direct oral anticoagulants and antiarrhythmic drugs: a systematic review of observational studies.直接口服抗凝剂与抗心律失常药物联合使用的有效性和安全性：观察性研究的系统评价
Eur J Clin Pharmacol. 2025 Jul 16. doi: 10.1007/s00228-025-03883-x.
本文引用的文献
1
A Structural Description of Biases That Generate Immortal Time.产生不朽时间偏差的结构描述。
Epidemiology. 2025 Jan 1;36(1):107-114. doi: 10.1097/EDE.0000000000001808. Epub 2024 Nov 4.
2
Risk of Opioid Overdose Associated with Concomitant Use of Methadone and Statins.与美沙酮和他汀类药物联合使用相关的阿片类药物过量风险。
Clin Pharmacol Ther. 2025 Feb;117(2):421-426. doi: 10.1002/cpt.3479. Epub 2024 Oct 21.
3
The Prevalent New-User Design to Study Drug-Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia.新兴药物相互作用研究的普遍设计：以磺酰脲类药物和华法林相互作用致严重低血糖风险为例。
Pharmacoepidemiol Drug Saf. 2024 Oct;33(10):e70014. doi: 10.1002/pds.70014.
4
Comparative Risk of Injury with Concurrent Use of Opioids and Skeletal Muscle Relaxants.同时使用阿片类药物和骨骼肌松弛剂的损伤风险比较。
Clin Pharmacol Ther. 2024 Jul;116(1):117-127. doi: 10.1002/cpt.3248. Epub 2024 Mar 14.
5
Core concepts in pharmacoepidemiology: Measurement of medication exposure in routinely collected healthcare data for causal inference studies in pharmacoepidemiology.药物流行病学中的核心概念：在常规收集的医疗保健数据中测量药物暴露情况，以便进行药物流行病学中的因果推断研究。
Pharmacoepidemiol Drug Saf. 2024 Mar;33(3):e5683. doi: 10.1002/pds.5683. Epub 2023 Sep 26.
6
Prevalence and trends of polypharmacy in U.S. adults, 1999-2018.1999-2018 年美国成年人多重用药的流行率和趋势。
Glob Health Res Policy. 2023 Jul 12;8(1):25. doi: 10.1186/s41256-023-00311-4.
7
Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP-4 Inhibitors: Population-Based Cohort Study.磺酰脲类药物和 DPP-4 抑制剂联合使用与严重低血糖风险的药物异质性：基于人群的队列研究。
Clin Pharmacol Ther. 2023 Sep;114(3):712-720. doi: 10.1002/cpt.2975. Epub 2023 Jul 1.
8
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance.药物-药物相互作用改变葡萄糖醛酸化药物的暴露：范围、尿苷二磷酸葡萄糖醛酸转移酶（UGT）酶选择性、机制（抑制和诱导）以及临床意义。
Pharmacol Ther. 2023 Aug;248:108459. doi: 10.1016/j.pharmthera.2023.108459. Epub 2023 May 30.
9
The Prevalent New-user Design for Studies With no Active Comparator: The Example of Statins and Cancer.无对照研究中新用户设计的流行：以他汀类药物与癌症为例。
Epidemiology. 2023 Sep 1;34(5):681-689. doi: 10.1097/EDE.0000000000001628. Epub 2023 May 12.
10
Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study.2型糖尿病患者中磺脲类药物与β受体阻滞剂的联合使用及严重低血糖风险：一项基于人群的队列研究
Diabetes Care. 2023 Feb 1;46(2):377-383. doi: 10.2337/dc22-1584.
Zotero 插件